CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Earnings Estimates
NASDAQ:CCRN • US2274831047
8.61 USD
+0.25 (+2.99%)
At close: Feb 20, 2026
8.5 USD
-0.11 (-1.28%)
After Hours: 2/20/2026, 8:21:17 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.807B 67.39% | 2.02B -28.04% | 1.344B -33.46% | 1.093B -18.68% | 1.034B -5.40% | 1.079B 4.35% | |
| EBITDA YoY % growth | 293.9M 89.61% | 135.516M -53.89% | 19.443M -85.65% | 29.966M 54.12% | 26.662M -11.03% | 29.409M 10.30% | |
| EBIT YoY % growth | 281.3M 93.87% | 117.169M -58.35% | 1.243M -98.94% | -13.925M -1,220.30% | 6.502M 146.69% | 672.517K -89.66% | |
| Operating Margin | 10.02% | 5.80% | 0.09% | -1.27% | 0.63% | 0.06% | |
| EPS YoY % growth | 5.26 71.90% | 2.21 -57.98% | 0.45 -79.64% | 0.11 -76.58% | 0.12 14.52% | 0.13 9.86% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.03 -23.50% | 0.02 -74.50% | 0.03 355.00% | 0.03 -15.00% | 0.03 | 0.02 33.33% | 0.04 60.00% | 0.04 60.00% | 0.04 33.33% |
| Revenue Q2Q % growth | 259.38M -16.31% | 261.9M -10.74% | 255.15M -6.90% | 250.89M 0.34% | 258.72M -0.25% | 277.4M 5.92% | 264.96M 3.84% | 257.18M 2.51% | 268.34M 3.72% |
| EBITDA Q2Q % growth | 6.809M -66.80% | 6.41M 4.45% | 6.462M -39.58% | 6.062M -55.97% | 7.284M 6.98% | 7.477M 16.65% | 6.678M 3.34% | 5.967M -1.57% | 7.613M 4.52% |
| EBIT Q2Q % growth | 75.888K -96.71% | 1.389M 1.76% | 1.778M -2.47% | 1.523M 88.96% | 2.068M 2,625.07% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.03 -75.00% | 0.04 | -0.01 | -19.79% |
| Q2 2025 Q2Q % growth | -0.01 -110.00% | 0.05 | -0.06 | -118.38% |
| Q1 2025 Q2Q % growth | 0.06 -68.42% | 0.06 | 0.00 | 5.59% |
| Q4 2024 Q2Q % growth | 0.04 -86.21% | 0.12 | -0.08 | -66.11% |
| Q3 2024 Q2Q % growth | 0.12 -69.23% | 0.10 | 0.02 | 22.23% |
| Q2 2024 Q2Q % growth | 0.10 -85.51% | 0.14 | -0.04 | -26.01% |
| Q1 2024 Q2Q % growth | 0.19 -77.38% | 0.17 | 0.02 | 8.77% |
| Q4 2023 Q2Q % growth | 0.29 -73.39% | 0.28 | 0.01 | 4.02% |
| Q3 2023 Q2Q % growth | 0.39 -63.55% | 0.42 | -0.03 | -6.09% |
| Q2 2023 Q2Q % growth | 0.69 -50.71% | 0.62 | 0.07 | 11.06% |
| Q1 2023 Q2Q % growth | 0.84 -50.59% | 0.76 | 0.08 | 10.21% |
| Q4 2022 Q2Q % growth | 1.09 -22.14% | 0.91 | 0.18 | 19.49% |
| Q3 2022 Q2Q % growth | 1.07 75.41% | 0.97 | 0.10 | 10.36% |
| Q2 2022 Q2Q % growth | 1.40 197.87% | 1.38 | 0.02 | 1.78% |
| Q1 2022 Q2Q % growth | 1.70 193.10% | 1.34 | 0.36 | 26.81% |
| Q4 2021 Q2Q % growth | 1.40 636.84% | 1.27 | 0.13 | 10.40% |
| Q3 2021 Q2Q % growth | 0.61 408.33% | 0.35 | 0.26 | 73.53% |
| Q2 2021 Q2Q % growth | 0.47 193.75% | 0.40 | 0.07 | 16.36% |
| Q1 2021 Q2Q % growth | 0.58 5,900.00% | 0.35 | 0.23 | 66.57% |
| Q4 2020 Q2Q % growth | 0.19 | 0.09 | 0.10 | 117.23% |
| Q3 2020 Q2Q % growth | 0.12 | -0.03 | 0.15 | 500.43% |
| Q2 2020 Q2Q % growth | 0.16 | -0.03 | 0.19 | 581.62% |
| Q1 2020 Q2Q % growth | -0.01 | -0.02 | 0.01 | 40.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 250.052M -20.65% | 276.17M | -26.118M | -9.46% |
| Q2 2025 Q2Q % growth | 274.072M -19.34% | 296.18M | -22.108M | -7.46% |
| Q1 2025 Q2Q % growth | 293.408M -22.62% | 311.59M | -18.182M | -5.84% |
| Q4 2024 Q2Q % growth | 309.94M -25.14% | 312.22M | -2.28M | -0.73% |
| Q3 2024 Q2Q % growth | 315.119M -28.75% | 316.42M | -1.301M | -0.41% |
| Q2 2024 Q2Q % growth | 339.771M -37.16% | 341.45M | -1.679M | -0.49% |
| Q1 2024 Q2Q % growth | 379.174M -39.11% | 381.57M | -2.396M | -0.63% |
| Q4 2023 Q2Q % growth | 414.035M -34.09% | 412.51M | 1.525M | 0.37% |
| Q3 2023 Q2Q % growth | 442.291M -30.47% | 452.78M | -10.489M | -2.32% |
| Q2 2023 Q2Q % growth | 540.695M -28.25% | 542.31M | -1.615M | -0.30% |
| Q1 2023 Q2Q % growth | 622.707M -21.05% | 606.9M | 15.807M | 2.60% |
| Q4 2022 Q2Q % growth | 628.2M -1.95% | 606.46M | 21.74M | 3.58% |
| Q3 2022 Q2Q % growth | 636.1M 69.67% | 629.89M | 6.21M | 0.99% |
| Q2 2022 Q2Q % growth | 753.6M 127.12% | 755.75M | -2.15M | -0.28% |
| Q1 2022 Q2Q % growth | 788.7M 139.58% | 760.55M | 28.15M | 3.70% |
| Q4 2021 Q2Q % growth | 640.7M 197.17% | 627.56M | 13.14M | 2.09% |
| Q3 2021 Q2Q % growth | 374.9M 93.25% | 326.88M | 48.02M | 14.69% |
| Q2 2021 Q2Q % growth | 331.8M 53.04% | 303.29M | 28.51M | 9.40% |
| Q1 2021 Q2Q % growth | 329.2M 56.69% | 294.98M | 34.22M | 11.60% |
| Q4 2020 Q2Q % growth | 215.6M | 200.35M | 15.25M | 7.61% |
| Q3 2020 Q2Q % growth | 194M | 178.06M | 15.94M | 8.95% |
| Q2 2020 Q2Q % growth | 216.8M | 202.87M | 13.93M | 6.87% |
| Q1 2020 Q2Q % growth | 210.1M | 214.22M | -4.12M | -1.92% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -9.99% | -33.33% | 0% | -26.19% |
| Revenue | 0% | -4.44% | 0% | -4.04% |